Intellia Therapeutics, Inc.NTLANASDAQ
LOADING
|||
Cash Flow Performance
Trending lower, below historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-30.77%
↓ 215% below average
Average (9y)
-9.78%
Historical baseline
Range
High:6.60%
Low:-30.77%
CAGR
+44.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -30.77% | -104.1% |
| 2023 | -15.08% | -3.4% |
| 2022 | -14.58% | -414.1% |
| 2021 | -2.84% | -61.5% |
| 2020 | -1.76% | +88.9% |
| 2019 | -15.88% | -38.0% |
| 2018 | -11.50% | -5.6% |
| 2017 | -10.89% | -265.0% |
| 2016 | 6.60% | +696.7% |
| 2015 | -1.11% | - |